SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

VENTRACOR LIMITED (VCR)

Delisted from ASX 31/08/2009

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

Shareholder links

 

REGISTRY:
Link Market Services,Level 21, 10 Eagle Street Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: C/- Clayton Utz , Level 28 , 71 Eagle Street , BRISBANE , QLD, AUSTRALIA, 4000
Tel:  (02) 9406 3100 Fax: (02) 9406 3101

Date first listed: 17/08/1993
Company Secretary: Ms Camilla Newcombe (Joint Co. Secretary), Mr Graeme Fallet (Joint Co. Secretary)
Sector: Health Care Equipment & Services
Industry Group: XHJ
Activities: Medical device company focused on commercialising the artificial heart??? device, the VentrAssist Left Ventricular Assist Device (LVAD)

company deregistered today

07/06/2013

delisted following failure to pay listing fees

31/08/2009

a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued

19/08/2009

we have twice requested that Steven Sherman of Ferrier Hodgson confirm whether his statement of 6 July 2009 (that it is not expected there will be any return to shareholders) constitutes a declaration pursuant to Section 104-145 of ITAA 1997, but we have received no reply

31/07/2009

at a creditors meeting today it is resolved to terminate the Deed of Company Arrangement and liquidate the company - it is not expected there will be any return to shareholders but the administrator/now liquidator S J Sherman has not made a formal loss declaration as yet

06/07/2009

the DOCA has failed and operations have ceased - options are being explored - a meeting of creditors on 3 July 2009 will determine the way forward

30/06/2009

in a release which reaches the market today at 6:16pm administrators advise that a second meeting of creditors is to be held at 10:00am today - a DOCA has been proposed - if it is not approved the administrators recommend liquidation

29/05/2009

the Company has not been able to attract sufficient capital to fund its operations through to 30 June 2009 - it has accordingly appointed Mr Steven Sherman and Mr John Gothard of Ferrier Hodgson to act as administrators

19/03/2009

company reports today that the US Bridge To Transplant (BTT) Trial of the VentrAssist Left Ventricular Assist Device (LVAD) has reached a successful completion

12/03/2009

company releases its Preliminary Final Report

27/02/2009

company reports today that enrolment in the US Bridge To Transplant (BTT) Trial of the VentrAssist Left Ventricular Assist Device (LVAD) is now complete at 140 patients - the first patient was enrolled in June 2007, and thus full enrolment of the trial took approximately eighteen months

12/02/2009

the securities of Ventracor Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the LVA4 VentraAssist LVAD, the Company's financial position and the status of discussions with third parties regarding the potential sale of the Company

10/02/2009

name changed from Micromedical Industries Limited

11/07/2002

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    John MasseyChairman
    Jane WilderGeneral Counsel
    Bernadette KerriganGeneral Counsel
    Andrew GeddesInvestor Relations

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.